(Q36443638)

14 August 2017

1 reference

title

Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls (English)

1 reference

14 August 2017

Dorothy M Keefe

1

1 reference

PubMed ID

16601949

14 August 2017

Douglas E Peterson

series ordinal

2

1 reference

PubMed ID

16601949

14 August 2017

Mark M Schubert

series ordinal

3

1 reference

14 August 2017

7 April 2006

1 reference

Supportive Care in Cancer

14 August 2017

1 reference

14 August 2017

14

1 reference

14 August 2017

6

1 reference

14 August 2017

492-498

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-006-0059-0

14 August 2017

0 references

cites work

Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference

1 reference

12 December 2020

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

1 reference

12 December 2020

Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer

1 reference

12 December 2020

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

12 December 2020

Rating the quality of evidence for clinical practice guidelines

1 reference

12 December 2020

The role of basic oral care and good clinical practice principles in the management of oral mucositis

1 reference

12 December 2020

Gastrointestinal mucositis: a new biological model

1 reference

12 December 2020

Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice

1 reference

12 December 2020

Anti-inflammatory agents in the management of alimentary mucositis

1 reference

12 December 2020

Promulgation of guidelines for mucositis management: educating health care professionals and patients

1 reference

12 December 2020

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

1 reference

12 December 2020

Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting

1 reference

12 December 2020

New thoughts on the pathobiology of regimen-related mucosal injury.

1 reference

12 December 2020

Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis

1 reference

12 December 2020

Alimentary mucositis: putting the guidelines into practice

1 reference

12 December 2020

Palifermin for oral mucositis after intensive therapy for hematologic cancers

1 reference

12 December 2020

10.1007/S00520-006-0059-0

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16601949